Until Labs is a biotechnology company focused on developing advanced cryopreservation technologies to pause biological time. The company specializes in creating perfusion hardware, cryoprotective agents, and rewarming infrastructure to enable the reversible cryopreservation of biological systems, particularly donor organs. By preserving organs at low temperatures for indefinite storage and rewarming them for transplant, Until Labs aims to improve organ matching and reduce organ wastage, ultimately enhancing the outcomes for transplant patients.